Laidlaw making bid in the financial markets

Relmada Therapeutics Inc. is a clinical firm that for a long time now is known for manufacturing of original therapies for chronic illness. In January 2016, it publicized it has filed a motion to amend its complaint against Laidlaw and company a (U.K) Ltd, in the U.S District Court for the District of Nevada. The firm had previously filed a complaint in the Nevada District Court.
The amendment complaint included a claim accusing Laidlaw and company and its principles James Ahern and Mathew Eitner of breach of contract that it owned Relmada after it disclosed confidential information that it acquired the period it acted as Relmada’s investment banker. In the filed case, Remelda is also seeking compensation for monetary damages received while responding to Laidlaw’s false and misinforming proxy materials in December 2015. Relmada board trust that Laidlaw must reimburse the indemnity it has inquired as of an effect of their action and it must be prevented from damaging the firm in the future.
Laidlaw & Company (UK ) LTD, is an investment banking and wealth management company, we offer our services to both corporate institutions and individuals in the United States and the United Kingdom. We are responsible for providing a broad range of financial services that include: capital rising through placement if equity, the arrangement of national exchange listing, placement of debt and mezzanine capital with institutional investors, acquisition financing and initial public offering. We also give financial advisory services on acquisitions and fairness opinion among others.
Laidlaw Company (UK) LTD has been experiencing tremendous growth since its inception. Recently together with our devoted principles James Ahern and Mathew Eitner we announced our firm’s expansion in our London offices with the additional of two members. The team will be responsible for the building of wealth management and the provision of access to the US capital markets to Healthcare firms based in Europe.

Leave a Reply

Your email address will not be published. Required fields are marked *